- Home
- QNCX vs TGE Comparison
QNCX vs TGE Comparison
Compare QNCX & TGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- TGE
- Stock Information
- Founded
- QNCX 2012
- TGE 2023
- Country
- QNCX United States
- TGE France
- Employees
- QNCX N/A
- TGE N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- TGE Newspapers/Magazines
- Sector
- QNCX Health Care
- TGE Consumer Discretionary
- Exchange
- QNCX Nasdaq
- TGE Nasdaq
- Market Cap
- QNCX 88.6M
- TGE 85.8M
- IPO Year
- QNCX 2019
- TGE N/A
- Fundamental
- Price
- QNCX $1.60
- TGE $1.27
- Analyst Decision
- QNCX Strong Buy
- TGE
- Analyst Count
- QNCX 6
- TGE 0
- Target Price
- QNCX $8.00
- TGE N/A
- AVG Volume (30 Days)
- QNCX 271.4K
- TGE 11.8M
- Earning Date
- QNCX 11-12-2025
- TGE 10-20-2025
- Dividend Yield
- QNCX N/A
- TGE N/A
- EPS Growth
- QNCX N/A
- TGE N/A
- EPS
- QNCX N/A
- TGE N/A
- Revenue
- QNCX N/A
- TGE $130,212,000.00
- Revenue This Year
- QNCX N/A
- TGE N/A
- Revenue Next Year
- QNCX N/A
- TGE N/A
- P/E Ratio
- QNCX N/A
- TGE $3.10
- Revenue Growth
- QNCX N/A
- TGE 81.03
- 52 Week Low
- QNCX $0.72
- TGE $0.78
- 52 Week High
- QNCX $2.45
- TGE $37.02
- Technical
- Relative Strength Index (RSI)
- QNCX 37.36
- TGE N/A
- Support Level
- QNCX $1.76
- TGE N/A
- Resistance Level
- QNCX $1.88
- TGE N/A
- Average True Range (ATR)
- QNCX 0.10
- TGE 0.00
- MACD
- QNCX -0.03
- TGE 0.00
- Stochastic Oscillator
- QNCX 9.28
- TGE 0.00
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About TGE The Generation Essentials Group Class A Ordinary Shares
The Generation Essentials Group is a media and entertainment company. Its publications L'Officiel and The Art Newspaper publish print editions in a total of nearly 28 countries and territories and digital contents. It operate in the movie production sector having produced various Asia-focused movies. It operate in three operating segments: media and entertainment segment, hotel operations, hospitality and VIP services segment and strategic investment segment. Key revenue is generated from strategic investment segment that is engage in proprietary investments and management of portfolio, including listed and unlisted equity shares investments and movie income right investments.